Cannell & Co. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cannell & Co. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$159,000
+65.6%
10,2000.0%0.01%
+25.0%
Q3 2020$96,000
+5.5%
10,2000.0%0.00%0.0%
Q2 2020$91,000
+40.0%
10,2000.0%0.00%
+33.3%
Q1 2020$65,000
-55.8%
10,200
-67.9%
0.00%
-40.0%
Q3 2016$147,000
-20.1%
31,7500.0%0.01%
-28.6%
Q2 2016$184,000
-4.2%
31,7500.0%0.01%0.0%
Q1 2016$192,000
+111.0%
31,750
+217.5%
0.01%
+133.3%
Q4 2015$91,00010,0000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RA Capital Management 6,000,000$66,540,0006.69%
FIC CAPITAL INC 787,529$8,734,0003.47%
RA Capital Management 1,220,209$13,532,0001.36%
PRINCETON CAPITAL MANAGEMENT INC 114,120$1,266,0000.67%
Perceptive Advisors 800,000$8,872,0000.53%
Cormorant Asset Management, LP 361,000$4,003,0000.53%
Highlander Capital Management, LLC 43,500$482,0000.43%
APEX CAPITAL, LLC 439,900$4,878,0000.42%
WASATCH ADVISORS LP 3,091,386$34,283,0000.37%
Baker Brothers Advisors 3,230,932$35,831,0000.31%
View complete list of SANGAMO THERAPEUTICS INC shareholders